The study also found FBP upregulation in clinical specimens of brain metastasis and growth inhibition when FBP is knocked down in orthotopic brain metastasis formed by breast cancer cells, suggesting that activation of FBP-based gluconeogenesis is important for the growth and survival of metastatic cancer cells in the brain. Here, FBP1 is linked to breast carcinoma.